Invention Grant
- Patent Title: Tricyclic heterocycles as BET protein inhibitors
-
Application No.: US15398907Application Date: 2017-01-05
-
Publication No.: US09938294B2Publication Date: 2018-04-10
- Inventor: Andrew P. Combs , Richard B. Sparks , Thomas P. Maduskuie, Jr. , James D. Rodgers
- Applicant: Incyte Corporation , Incyte Holdings Corporation
- Applicant Address: US DE Wilmington US DE Wilmington
- Assignee: Incyte Corporation,Incyte Holdings Corporation
- Current Assignee: Incyte Corporation,Incyte Holdings Corporation
- Current Assignee Address: US DE Wilmington US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D498/06
- IPC: C07D498/06 ; C07D498/04 ; C07D498/16 ; C07D471/06 ; C07D519/00
Abstract:
The present invention relates to tricyclic heterocycles of Formula (I): which are inhibitors of BET proteins such as BRD2, BRD3, BRD4, and BRD-t and are useful in the treatment of diseases such as cancer.
Public/Granted literature
- US20170210754A1 TRICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS Public/Granted day:2017-07-27
Information query
